Pseudomonas aeruginosa harbours virulence and antibiotic resistance genes that contribute to life-threatening infections. In silico PCR amplification detected both virulence and antibiotic resistance genes of eighteen Pseudomonas aeruginosa isolates. L lipoprotein (oprL) gene was found in 72.22% of the isolates and is used usually to rapidly identify Pseudomonas aeruginosa species. Alkaline protease (apr) was detected in 66.67% of the isolates. Protein biosynthesis inhibited by exotoxin A (exoA), was found in 55.56% of the isolates. Fifty percent (n=9) of the isolates had the exoenzyme S (exoS) and elastase (lasB) genes. Thirteen isolates (72.22%) which harboured the phospholipid C (plcH) genes, were also found to be positive for rhamnolipid AB (rhlAB) genes. Thirteen isolates (72.22%) were found to possess alginate (algD) and neuraminidae (nan2) genes, respectively. Pseudomonas aeruginosa PA7 harboured both aph(3") and aph(6)-1d genes. Only sulfonamide resistance gene, sul1 was present in 11.11% (n=2) of the isolates. Beta-lactamase gene, blaTEM was present in only one isolate and no tetracycline resistance gene was found. Fluoroquinolone resistance-determining region of the gyrA and parC genes were present in fourteen (77.78%) and thirteen (72.22%) isolates, respectively. Pseudomonas aeruginosa NCGM2.S1 is a multidrug resistant bacterium since it harboured class 1 integrase gene. In silico pulsed-field gel electrophoresis (PFGE) analysis was able to group eighteen isolates into three genotypes. Gene distribution pattern within genotypes was almost similar and not dependent on genotypes. The data generated here helps to predict virulence and antibiotic resistance profile of Pseudomonas aeruginosaspecies based on genotype.
INTRODUCTION
Pseudomonas aeruginosa is a gram-negative opportunistic pathogen that infects virtually all tissues. Fegan et al. (1990) reported that P. aeruginosa is colonized on respiratory tract and contributed to cystic fibrosis infection. Yetkin et al. (2006) reported that P. aeruginosa is responsible for nosocomial infection and affects patients in intensive care units. Pollack (2000) stated that immunocompromised cancer patients, burn patients and catheterized patients also suffer from serious infections that are caused by P. aeruginosa. Trautner and Darouiche (2004) reported that biofilms developed by P. aeruginosa are attached to the site of infection and caused chronic and recurrent infections. Pseudomonas is responsible for waterborne outbreaks of dermatitis, conjunctivitis and otitis media (Adesoji et al., 2015) . Van Delden and Iglewski (1998) stated that virulence properties of P. aeruginosa are tightly regulated by cell to cell signaling systems. Virulence factors of P. aeruginosa are divided into specific groups such as adhesins or other secreted exotoxins. Bradbury et al. (2010) reported that type I (TISS), type II (T2SS) or type III (T3SS) secretion system actively secreted exotoxins. Bradbury et al. (2010) also stated that previous studies have found the association of virulence factors with different diseases.
Protein synthesis inhibiting exotoxin A was reported earlier by Thamir and Al-Jubori (2014) . Khattab et al. (2015) demonstrated that PCR based amplification of L lipoprotein (oprL) is used for identification of the species of Pseudomonas. Pollack (2000) demonstrated that multidrug-resistant P. aeruginosa is medically important and caused several infections. Antibiotic resistance genes can be transferred between different microorganisms with the help of integrase gene, int1 (Adesoji et al., 2015) . Yah et al. (2006) , Bonomo and Szabo (2006) , Chen et al. (2009) reported that plasmids or transposons also contributed to developing multidrug-resistant Pseudomonas. Strateva and Yordanov (2009) concluded that risk factors identification for multidrug-resistant Pseudomonas is important to minimize this problem. Several clinical studies are needed to minimize severe infections caused by Pseudomonas and maximize the outcomes in the treatment of infectious diseases. The aim of the present study is to characterize the virulence and antibiotic resistance property of 18 Pseudomonas aeruginosa isolates by PCR and to find the distribution in genotypes based on pulsed field gel electrophoresis (PFGE).
MATERIALS AND METHODS Strains used in the study
Strains used in the study are summarized in Table 1 .
Primer used in the study
Primer used for virulence and antibiotic resistance gene detection in the study are summarized in Table 2 and 3.
PCR amplification
In silico PCR amplification was done in the website http://insilico.ehu.eus/PCR/ (San Millán et al., 2013; Bikandi et al., 2004) .
PFGE digestion
Pulsed field gel electrophoresis (PFGE) digestion was done in the website http://insilico.ehu.es/digest/ (San Millán et al., 2013; Bikandi et al., 2004) . The enzyme used for the digestion was PacI. Banding patterns were scored in a binary matrix and a dendrogram was constructed using Complete Linkage method by SPSS 16 (IBM, USA). 
RESULTS AND DISCUSSION
Eighteen isolates were subjected to pulsed-field gel electrophoresis (PFGE) analysis with Pacl restriction digestion. The recognition sequence of Pacl restriction digestion was TTA_AT'TAA. Twenty-five distinct band sizes were observed upon gel electrophoresis. The banding patterns were converted to binary data and this data can be interpreted by SPSS software to form a dendrogram ( Fig. 1) . It was able to group the 18 isolates into 3 genotypes at 20% dissimilarity cutoff value. Genotype 1 was more prevalent (77.7%) (Fig. 2) . Genotype 2 and genotype 3 were found to contain 11.11% of the isolates. Virulence factors of Pseudomonas spp. tightly regulated by cell to cell signaling systems was reported by Van Delden and Iglewski (1998) . Total eighteen isolates were studied for virulence and antibiotic resistance genes. Out of eighteen isolates, 13 isolates had the L lipoprotein (oprL) with 504 bp gene product. de Vos et al. (1999) , Masuda et al. (1995) and Nikaido (1994) previously described that P. aeruginosa contained outer membrane protein L (oprL) that is responsible for inherent resistance to antibiotics and antiseptics. This oprL gene is used as a marker for rapid identification of P. aeruginosa species. According to previous studies (Pitt, 1998; Engel, 2003) collagen, C1q and C3 of the complement pathway, serum protease inhibitors, fibrin, fibrinogen, laminen and elastin are the substrates of alkaline protease, apr. Twelve isolates were found to possess apr gene and produce 1017 bp gene product. Hence the prevalence was 55.56%. Genotypic distributions were similar in genotype 2 and 3 (Fig. 3) .
All the isolates present in genotype 2 and 3 harboured oprL and apr genes (100%). Gene distribution patterns were different in genotype 1 and 64.29% and 57.14% present in genotype 1 carried oprL and apr genes, respectively. Sabharwal et al. (2014) identified that only P. aeruginosa contained exotoxin A (toxA) gene, whereas other species of this genus did not yield toxA gene. Out of the 18 isolates, 10 (55.56%) isolates had the exotoxin A genes (toxA) with an approximate length of 250 bp. Hamood (2004) reported that protein biosynthesis is inhibited by the action of exotoxin A (toxA). Nikbin et al. (2012) described that toxA gene was found in 90.7% P. aeruginosa isolated from burn, wound and pulmonary tract infections sample. According to Riese et al. (2002) and Anthonv et al. (2007) , type-III secretion system directly secrete exoenzyme S (exoS) into the cytosol of human epithelial cell and other studies (Olson et al., 1999; Yahr et al., 1996) found that this inactivated cellular function, inhibited DNA synthesis and microvillus effacement. Nine isolates were found to possess exoenzyme S (exoS) and gave 504 bp gene product. So, the percentage of prevalence was 50. Recently, Thamir and Jubori (2014) described that exoS gene was present in higher number in samples collected from cystic fibrosis patients, wound, urine and blood than from sputum and bronchial washer. The 283 bp gene product of lasB gene was found in nine isolates. Hence the prevalence was 50%. Sabharwal et al. (2014) reported that elastin, collagen, fibronectin and laminin are substrates of T2SS secreted proteolytic enzyme, lasB gene. Elastase, lasB gene showed elastolytic activity on human lung tissue and was reported by Lomholt et al. (2001) . Phospholipase C (plcH) hydrolyzing phospholipid was reported by Sabharwal et al. (2014) . The plcH gene produces 307 bp gene product and 13 isolates (72.22%) were found to express plcH genes. Proinflammatory activities and pulmonary inflammation caused by phospholipase C (plcH) was reported by Wieland et al. (2002) . Terada et al. (1999) examined that oxidative burst of neutrophils is also inhibited by phospholipase C (plcH). Genotypic distribution of exotoxin A (toxA), exoenzyme S (exoS), elastase (lasB) and phospholipase C (plcH) gene was similar in genotype 2 and 3 (Fig. 4) . All the isolates present in genotype 2 and 3 harboured these four genes (100%). Low prevalence of exoS and lasB gene were encountered in genotype 1 (35.71%) while 42.86% and 64.29% isolates present in genotype 1 contained toxA and plcH genes, respectively. Isolates were also screened for rhamnolipid AB (rhlAB), alginate (algD) and putative neuraminidase (nan2). Isolates those harboured plcH genes were also found to be positive for rhamnolipid AB (rhlAB) gene. The rhlAB gene produces 151 bp gene product. Van and Iglewski (1998) reported that phospholipids of lung surfactant are solubilized by rhamnolipid and this solubilized phospholipid is more easily cleaved by phospholipid C (plcH). Thirteen isolates were found to possess alginate (algD) genes and produced 1311 bp gene product. Hence the prevalence was 72.22%. Govan and Deretic (1996) described that chronic pulmonary inflammation is caused by alginate (algD) gene. It also helps to escape host immune surveillance and provide protection from antibiotics. Putative neuraminidase (nan2) was found in 72.22% of the isolates with 1161 bp gene product. Daniel et al. (2007) reported that spreading of P. aeruginosa within the host cells is mediated by neuraminidase gene. Neuraminidase also required for implantation of the bacterium was described by Cacalano et al. (1992) and Davies et al. (1999) . Genotypic distribution of rhlAB, algD and nan2 gene was similar in all genotypes (Fig. 5) . All the isolates present in genotype 2 and 3 carried these three genes (100%) while 64.29% isolates present in genotype 1 expressed all these three genes. Antibiotic resistance is now a global concern. Isolates were tested for the streptomycin resistance genes. The aph(6)-1d gene produces 560 bp gene product and was present in Pseudomonas aeruginosa PA7. P. aeruginosa PA7 isolate was also found to express 515 bp gene product for aph(3") gene. Only P. aeruginosa NCGM2.S1 isolate had the ant(3") gene with 294 bp gene product. So, isolate P. aeruginosa PA7 hariboured both aph (3") and aph (6)-1d genes. Adesoji et al. (2015) also reported about a Pseudomonas bacterium that carried more than one streptomycin resistance genes. These isolates had the aminoglycoside modifying enzyme. Llano-Sotelo et al. (2002) reported that antibiotic molecule is modified by AMEs enzyme that linked antibiotic molecule with phosphate, adenyl or acetyl radical. Thus, modified antibiotics could not bind with its target. Aminoglycoside modifying enzyme (AME) genes which includes aac(6')-I and ant(2")-I, were found in 50 and 45% of Pseudomonas isolates, respectively as reported by Odumosu et al. (2003) . Seveno et al. (2002) examined that streptomycin resistance is high in clinical and agricultural habitats. Genotype 2 and 3 carried no streptomycin resistance gene (Fig. 6 ). Gene distribution pattern was similar in genotype 1 and 14% isolates present in genotype 1 harboured these three genes. Sulfonamide resistance gene, sul1 was present in 2 isolates (11.11%) (P. aeruginosa NCGM2.S1, P. aeruginosaPA7) with an amplicon of 433 bp. No isolate harboured the sul2 and sul3 gene. Adesoji et al. (2015) also found sulfonamide resistance gene sul1 (31.8%) and no sul3 genes. But their study found sul2 gene (27.3%). Only P. aeruginosa NCGM2.S1 had the bla TEM gene with 425 bp gene product. The bla SHV gene was not present in any one of the isolates. Adesoji et al. (2015) found that among the beta lactamase gene, bla TEM gene was more prevalent (40.9%) than bla SHV (27.3%). Bradford (2001) reported that enterobacteriaceae mainly harboured the enzyme, bla TEM and bla SHV. However, Pseudomonas harboured the bla TEM and bla SHV gene possibly due to the overuse of beta lactam antibiotics. Adesoji et al. (2015) examined that tetracycline resistance of tet(A), tet(B), and tet(E) gene is acquired by efflux pump system and for tet (O) and tet(M) gene, resistance mechanism is developed by ribosomal protection. No isolate was found that contained tetracycline resistance tet(A), tet(B) or tet(M) gene. Zhang et al. (2009) stated that various environmental genera carried the broad host range tetracycline resistance gene tet(A). Shababi et al. (2011) studies found that the prevalence of tet(B) gene was higher than tet(A)gene of P aeruginosa samples isolated from municipal sewage. Genotype 2 and 3 contained no sulfonamide, sul1 or beta lactamase bla TEM resistance genes (Fig. 7) . The sul1 and bla TEM genes were present in 14.29% and 7.14% isolates in genotype 1. Fazeli and Momtaz (2014) demonstrated that multiplex PCR assays were used to detect fluoroquinolone resistancedetermining region of the gyrA and parC gene. Fourteen isolates were found to express gyrA genes with an approximate length of 287 bp. So, the percentage of prevalence was 77.78. Strateva and Yordanov (2009) described that gyrA gene is modified within the enzyme's active site, quinolone-resistant-determinative region by a point mutation and changed the amino acid sequence of A and B subunits. This alteration created low affinity quinolone molecules. PCR amplification of parC gene produces 267 bp gene product. Thirteen isolates (72.22%) had the parC genes. All the isolates present in genotype 2 and 3 carried gyrA and parC genes (100%) (Fig. 8) . Genotype 1 also harboured gyrA and parC genes and 71.43% and 64.3% isolates present in genotype 1 expressed gyrA and parC genes, respectively. Class 1 integrase, int1 was found in only isolate Pseudomonas aeruginosa NCGM2.S1. No isolate was found to harbour class 2 integrase, int2. Mazel (2006) , Rowe-Magnus and Mazek (2002) studied class 1 integrase and described that class 1 integrase facilitate the ability to shuttle antibiotic resistance genes 7.14 7.14 7.14 between different bacterial species. Isolates P. aeruginosa NCGM2.S1 contained class 1 integron gene and is considered as a multidrug resistant bacterium. Variable region of class 1 integron was found in one isolate (P. aeruginosa NCGM2.S1). Adesoji et al. (2015) concluded that the variable region of class 1 integrase helps to insert antibiotic resistant cassette in the integrase sequence. Class 1 integrase and variable region of class 1 integron genes were absent in genotype 2 and 3 (Fig. 9) . Genotype 1 harboured similar number of class 1 integrase and variable region of class 1 integron gene (7.14%). 
CONCLUSION
Identification of L lipoprotein, oprL precisely and rapidly identify P. aeruginosa species. Gene distribution pattern of virulence and antibiotic resistance genes within genotypes were almost similar. Different virulent genes are identified that may contribute to virulence and pathogenicity of the infections. The data has provided epidemiological information to study the characteristics of the P. aeruginosa and also the virulence factors associated with infections. Pseudomonas harbouring class 1 integron spread the antibiotic resistance gene in the environment which is now a global concern. This multidrug resistant Pseudomonas may contribute to many emergence and reemergence infectious diseases. Finally clinical studies are needed to control multidrug-resistant Pseudomonas and maximize the clinical outcomes in the treatment of infectious diseases. 
